Browsing: GLP1s

Data from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA), specifically its Yellow Card Biobank, suggests that GLP-1s are not only linked to deaths but thousands of instances of other, less serious symptoms, such as gastrointestinal issues and nervous system disorders

GLP-1 medications have become one of the most closely watched tools in metabolic health, and for good reason. These medications can help regulate appetite, improve blood sugar control, and drive levels of weight loss that were once difficult to achieve without surgery. But a new review of 19 clinical trials indicates that different GLP-1s can have…